Soligenix
- Pharmaceutical Preparations
- Princeton, New Jersey
Compensation history
Top executives at Soligenix received an average of $440K per person in annual compensation from 2006 to 2022.
Average pay of disclosed executives at Soligenix
By year
Executives
We found 14 executives who work or worked at Soligenix.
Christopher Schaber
Soligenix
Chief Executive Officer
Jonathan Guarino
Soligenix
Chief Financial Officer
Oreola Donini
Soligenix
Chief Scientific Officer
Richard Straube
Soligenix
Chief Marketing Officer
Oreola CSO
Soligenix
Senior VP
Karen Krumeich
Soligenix
Chief Financial Officer
Joseph Warusz
Soligenix
Chief Financial Officer
Robert CSO
Soligenix
Senior VP
News
Soligenix CEO Christopher Schaber's 2022 pay rises 3% to $711K
August 7, 2023
Soligenix CEO Christopher Schaber's 2021 pay falls 27% to $687K
August 5, 2022
Soligenix CEO Christopher Schaber's 2019 pay rises 11% to $688K
August 7, 2020
Soligenix CEO Christopher Schaber's 2018 pay falls 30% to $619K
July 26, 2019
Soligenix CEO Michael Sember receives $504K in 2006
August 17, 2007
About Soligenix
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address29 Emmons Drive, Suite B-10, Princeton, New Jersey 08540
- Phone609-538-8200
- Fiscal year endDecember 31
- Former names
- DOR BIOPHARMA INCUntil September 28, 2009
- ENDOREX CORPUntil October 23, 2001
- IMMUNOTHERAPEUTICS INCUntil April 29, 1996
Source: SEC filings on August 7, 2023, August 5, 2022, August 7, 2020, August 10, 2018, May 2, 2016, May 8, 2014, August 14, 2013, May 10, 2011, August 11, 2010, April 16, 2009, and August 17, 2007.